| Literature DB >> 23855907 |
Benedetta Cesqui1, Peppino Tropea, Silvestro Micera, Hermano Igo Krebs.
Abstract
BACKGROUND: Several studies investigating the use of electromyographic (EMG) signals in robot-based stroke neuro-rehabilitation to enhance functional recovery. Here we explored whether a classical EMG-based patterns recognition approach could be employed to predict patients' intentions while attempting to generate goal-directed movements in the horizontal plane.Entities:
Mesh:
Year: 2013 PMID: 23855907 PMCID: PMC3729537 DOI: 10.1186/1743-0003-10-75
Source DB: PubMed Journal: J Neuroeng Rehabil ISSN: 1743-0003 Impact factor: 4.262
Demographic and clinical data of patients with spastic hemiparesis
| P1 | M | H | Right frontal-temporal | L | R | 15 |
| P2 | M | H | Unavailable in medical records | R | R | 18 |
| P3 | F | I | Left caudate nucleus and thalamus | R | R | 19 |
| P4 | M | H | Left Internal Capsule | R | R | 19 |
| P5 | M | I | Right cortical-subcortical precentral | L | R | 21 |
| P6 | M | H | Unavailable in medical records | R | R | 30 |
| P7 | M | I | Right cortical-subcortical parietal | L | R | 36 |
The rightmost column reports the Fugl–Meyer clinical rating of loss of sensorimotor function in the arm: 15 = severe, 36 = minimal. Labels in the 3rd, 4th, 6th, and 7th columns refer to: F Female, M Male, H Hemorragic, I Ischemic, L Left, R Right.
Figure 1The experimental setup. (A) Robotic Therapy at Burke Rehabilitation Hospital. (B) Targets position distribution on the horizontal plane.
Application of the Davies–Boulding in method for the signal features selection
| HISTogram parameter ( HIST ) | 0.53 |
| Zero Crossing parameter (ZC) | 0.70 |
| Auto Regressive coefficients (AR) | 1.01 |
| Integral Absolute Value (IAV) | 1.24 |
GROUP I: classification results
| TEST 1 SVM trained and tested with individual data | 93.9 ± 4.4 |
| TEST 2 SVM trained with dataset from a composite of all subjects and tested with the remaining dataset | 89.6 ± 4.4 |
| TEST 3 SVM trained with dataset from a composite of 7 subjects and tested with a dataset from 2 worst subjects | 79.1 |
| TEST 4 SVM trained with dataset from a composite of 7 subjects and tested with a dataset from 2 good subjects | 97.5 |
Percentage of correct classification for each test carried out in the case of healthy subjects.
GROUP I: classification results of TEST 2-3-4 (see Methods)
| TEST 2 | North | 84.1 | 11.7 | 5.6 | 0 |
| East | 12.1 | 88.3 | 0 | 0 | |
| South | 3.8 | 0 | 91.8 | 6.6 | |
| West | 0 | 0 | 2.6 | 93.4 | |
| TEST 3 | North | 45 | 0 | 14.3 | 0 |
| East | 55 | 100 | 0 | 0 | |
| South | 0 | 0 | 71.4 | 0 | |
| West | 0 | 0 | 14.3 | 100 | |
| TEST 4 | North | 100 | 10 | 0 | 0 |
| East | 0 | 90 | 0 | 0 | |
| South | 0 | 0 | 100 | 0 | |
| West | 0 | 0 | 0 | 100 | |
GROUP II: classification results and confusion matrices for TEST2
| P1 | North | 40 | 0 | 0 | 40 |
| 35% | East | 0 | 0 | 0 | 0 |
| South | 60 | 100 | 100 | 60 | |
| West | 0 | 0 | 0 | 0 | |
| P2 | North | 20 | 0 | 0 | 0 |
| 35% | East | 60 | 20 | 0 | 0 |
| South | 20 | 80 | 100 | 100 | |
| West | 0 | 0 | 0 | 0 | |
| P3 | North | 80 | 100 | 80 | 100 |
| 25% | East | 20 | 0 | 0 | 0 |
| South | 0 | 0 | 20 | 0 | |
| West | 0 | 0 | 0 | 0 | |
| P4 | North | 20 | 0 | 0 | 0 |
| 30% | East | 0 | 0 | 0 | 0 |
| South | 80 | 100 | 100 | 100 | |
| West | 0 | 0 | 0 | 0 | |
| P5 | North | 40 | 0 | 0 | 0 |
| 45% | East | 60 | 40 | 0 | 40 |
| South | 0 | 60 | 100 | 60 | |
| West | 0 | 0 | 0 | 0 | |
| P6 | North | 20 | 0 | 0 | 0 |
| 35% | East | 0 | 0 | 0 | 0 |
| South | 80 | 100 | 100 | 100 | |
| West | 0 | 0 | 0 | 0 | |
| P7 | North | 0 | 0 | 20 | 0 |
| 35% | East | 20 | 0 | 0 | 0 |
| South | 80 | 80 | 80 | 40 | |
| West | 0 | 20 | 0 | 60 | |
Elements on the left-right diagonal indicate the percentage of correct classification, while elements on the off-diagonals denote percentage of misclassification. SVM was trained with data from GROUP I and validated individually on each patient with the muscle dataset selected for healthy subjects (see Methods).
GROUP II: classification results and confusion matrices for TEST1
| P1 | North | 28.6 | 25 | 0 | 58.3 |
| 43.3% | East | 14.3 | 75 | 28.6 | 16.7 |
| South | 42.9 | 0 | 71.4 | 0 | |
| West | 14.3 | 0 | 0 | 25 | |
| P2 | North | 100 | 0 | 0 | 0 |
| 70% | East | 0 | 77.8 | 0 | 0 |
| South | 0 | 22.2 | 85.7 | 60 | |
| West | 0 | 0 | 14.3 | 40 | |
| P3 | North | 42.9 | 26.6 | 0 | 0 |
| 30% | East | 0 | 28.6 | 66.7 | 28.6 |
| South | 28.6 | 42.9 | 11.1 | 28.6 | |
| West | 28.6 | 0 | 22.2 | 42.9 | |
| P4 | North | 12.5 | 57.1 | 0 | 0 |
| 26.7% | East | 87.5 | 28.6 | 0 | 0 |
| South | 0 | 14.3 | 37.5 | 71.4 | |
| West | 0 | 0 | 62.5 | 28.6 | |
| P5 | North | 14.3 | 0 | 0 | 20 |
| 40% | East | 28.6 | 57.1 | 16.7 | 20 |
| South | 14.3 | 42.9 | 83.3 | 40 | |
| West | 42.9 | 0 | 0 | 20 | |
| P6 | North | 83.3 | 0 | 0 | 0 |
| 70% | East | 16.7 | 45.5 | 12.5 | 0 |
| South | 0 | 54.5 | 75 | 0 | |
| West | 0 | 0 | 12.5 | 100 | |
| P7 | North | 100 | 0 | 0 | 0 |
| 66.7% | East | 0 | 57.1 | 60 | 0 |
| South | 0 | 42.9 | 40 | 0 | |
| West | 0 | 0 | 0 | 100 | |
Elements on the left-right diagonal indicate the percentage of correct classification, while elements on the off-diagonals denote percentage of misclassification. SVM was trained (70% of trials) and tested (30% of trials) individually on each patient with the muscle dataset selected for healthy subjects; training and testing data were randomly selected and mutually exclusive; test was repeated 5 times for each patient and accuracy rates were averaged across iterations.
GROUP II: classification results and confusion matrices for TEST3
| P1 | North | 66.7 | 20 | 25 | 14.3 |
| 53.3% | East | 16.7 | 40 | 41.7 | 0 |
| South | 0 | 20 | 33.3 | 0 | |
| West | 16.7 | 20 | 0 | 85.7 | |
| P2 | North | 100 | 0 | 0 | 0 |
| 70% | East | 0 | 87.5 | 0 | 0 |
| South | 0 | 0 | 27.3 | 0 | |
| West | 0 | 12.5 | 72.7 | 100 | |
| P3 | North | 66.7 | 25 | 0 | 0 |
| 36.7% | East | 16.7 | 75 | 75 | 50 |
| South | 0 | 0 | 0 | 0 | |
| West | 16.7 | 0 | 25 | 50 | |
| P4 | North | 28.6 | 12.5 | 0 | 12.5 |
| 36.7% | East | 57.1 | 37.5 | 14.3 | 12.5 |
| South | 14.3 | 50 | 57.1 | 50 | |
| West | 0 | 0 | 28.6 | 25 | |
| P5 | North | 25 | 14.3 | 0 | 33.3 |
| 43.3% | East | 37.5 | 57.1 | 16.7 | 0 |
| South | 12.5 | 28.6 | 83.3 | 44.4 | |
| West | 25 | 0 | 0 | 22.2 | |
| P6 | North | 87.5 | 0 | 0 | 0 |
| 83.3% | East | 12.5 | 71.4 | 12.5 | 0 |
| South | 0 | 28.6 | 75 | 0 | |
| West | 0 | 0 | 12.5 | 100 | |
| P7 | North | 100 | 0 | 0 | 14.3 |
| 70% | East | 0 | 50 | 55.6 | 14.3 |
| South | 0 | 50 | 44 | 0 | |
| West | 0 | 0 | 0 | 71.4 | |
Elements on the left-right diagonal indicate the percentage of correct classification, while elements on the off-diagonals denote percentage of misclassification. SVM was trained (70% of trials) and tested (30% of trials) individually on each patient with the muscle dataset recorded during the experimental session (see Methods); training and testing data were randomly selected and mutually exclusive; test was repeated 5 times for each patient and accuracy rates were averaged across iterations.
Figure 2CoE parameter directional tuning. Modulation of the CoE parameter across the four aimed directions (N, E, S, W) for each recorded muscle are shown respectively for the healthy subjects group (GR I) and for each patient enrolled in the study. CoE coefficients of each muscle were averaged across repeated trials and, in the case of GR I, also across different subjects (CoE_M). The polar diagrams show the distribution of the CoE_M ±1.96 · SE (SE = Standard Error) coefficients connected by periodic cubic spline interpolation curves. The resulting area inside the curves represents the 95% confidence interval of the CoE distribution for each muscle. Dashed black lines are circles of unit radius. Muscles were ordered according to their relevance in motion production in each direction observed for GR I: in particular TR was responsible for motion toward North direction, DM and DP toward East direction, UT and BI toward South direction, and PM and DA toward West direction.
Figure 3Examples of end-point kinematic and EMG signals collected during one trial in the 600 ms condition from one healthy subject. Top panel: endpoint trajectories are shown for each movement direction (columns). Central panels: EMG signals are shown for each muscle (rows) and movement direction (columns); data were full wave rectified and normalized with respect to the maximum of the specific muscle over all conditions, filtered (see Methods section), and integrated over 10 ms intervals; the gray area represents the time window used for the present analysis; muscles abbreviation are defined in the Methods section. Bottom panel: tangential velocity profiles are shown for each movement direction (columns). Data are aligned to the movement onset.
Figure 4Examples of end-point kinematic and EMG signals collected during one trial from one pathological subject (P1). Top panel: endpoint trajectories are shown for each movement direction (columns). Central panels: EMG signals are shown for each muscle (rows) and movement direction (columns); data were full wave rectified and normalized with respect to the maximum of the specific muscle over all conditions, filtered (see Methods section), and integrated over 10 ms intervals; the gray area represents the time window used for the present analysis; muscles abbreviation are defined in the Methods section. Bottom panel: tangential velocity profiles are shown for each movement direction (columns). Data are aligned to the movement onset.